Opella Raids FMCG Playbook, BelliWelli Wins Walmart

Opella is rewriting how consumer healthcare brands market themselves — and BelliWelli's Walmart debut proves culture beats clinical claims at mass retail. Here's what both moves mean for your strategy. In this episode: Opella, the consumer healthcare company behind Allegra and Dulcolax, is explicitly shifting to FMCG-style brand-building — high-reach, entertainment-led campaigns — raising real questions about how OTC brands maintain regulatory credibility while chasing consumer reach. Kratom is being sold across European wellness channels on anti-ageing and energy claims with zero EFSA-approved health claims and no EU novel food authorisation, with Italian outlet Il Fatto Alimentare flagging documented risks including dependency and toxicity. A new study found that higher sugar intake during antibiotic courses amplifies gut microbiome disruption and increases growth of potentially harmful bacteria, giving probiotic and gut health brands a timely, evidence-based hook for microbiome recovery positioning. Fibre and gut health brand BelliWelli launched into Walmart with a culture-first playbook — celebrity cameos, fashion brand collaborations, and giveaways — deliberately leading with lifestyle relevance over health claims to drive trial at mass retail scale. The Health Marketing Daily is a concise briefing for marketers and founders in supplements, functional food and consumer health, hosted by Marco & Klara. New episode every day. Enjoying the show? A quick rating or review on Apple Podcasts or Spotify helps other marketers find us. Also from Marco & Klara: The FMCG Marketing Daily · The Digital Commerce Daily